House Engrossed Senate Bill

 

psilocybin services; regulation; licensure

(now: approved medication; rescheduling; controlled substance)

 

 

 

State of Arizona

Senate

Fifty-seventh Legislature

First Regular Session

2025

 

 

 

CHAPTER 231

 

SENATE BILL 1555

 

 

 

An Act

 

amending section 36-2511, Arizona Revised Statutes, as amended by laws 2021, chapter 61, section 12; amending section 36-2511, Arizona Revised Statutes, as amended by laws 2023, chapter 97, section 1; amending title 36, chapter 27, article 2, Arizona Revised Statutes, by adding section 36-2517.02; relating to controlled SUBSTANCES.

 

 

(TEXT OF BILL BEGINS ON NEXT PAGE)

 

Be it enacted by the Legislature of the State of Arizona:

Section 1. Section 36-2511, Arizona Revised Statutes, as amended by Laws 2021, chapter 61, section 12, is amended to read:

START_STATUTE36-2511. Nomenclature

The controlled substances listed or to be listed in the schedules in sections 36-2512, 36-2513, 36-2514, 36-2515, 36-2516, and 36-2517 and 36-2517.02 or the rules adopted pursuant to this article are included by whatever official, common, usual, chemical or trade name designated. END_STATUTE

Sec. 2. Section 36-2511, Arizona Revised Statutes, as amended by Laws 2023, chapter 97, section 1, is amended to read:

START_STATUTE36-2511. Nomenclature

The controlled substances listed or to be listed in the schedules in sections 36-2512, 36-2513, 36-2514, 36-2515, 36-2516, 36-2517, and 36-2517.01 and 36-2517.02 or the rules adopted pursuant to this article are included by whatever official, common, usual, chemical or trade name designated. END_STATUTE

Sec. 3. Title 36, chapter 27, article 2, Arizona Revised Statutes, is amended by adding section 36-2517.02, to read:

START_STATUTE36-2517.02. United States food and drug administration; approved medication; rescheduling

Any pharmaceutical composition of crystalline polymorph psilocybin that is approved by the United States food and drug administration and rescheduled by the United States drug enforcement administration to a schedule other than schedule I of the controlled substances act (P.L. 91-513; 84 Stat. 1242; 21 United States Code sections 801 through 904) is a controlled substance for the purposes of this chapter and may be prescribed in this state. END_STATUTE

Sec. 4. Legislative intent

If crystalline polymorph psilocybin is approved by the United States food and drug administration and rescheduled by the United States drug enforcement administration, it is this legislature's intent that patients have rapid access to this treatment option.

Sec. 5. Conditional enactments; notice

A. Section 36-2511, Arizona Revised Statutes, as amended by Laws 2021, chapter 61, section 12 and this act, section 36-2517.02, Arizona Revised Statutes, as added by this act, and section 4 of this act do not become effective unless on or before January 1, 2031 crystalline polymorph psilocybin is newly approved as a prescription medication pursuant to 21 United States Code section 355 and is controlled under a federal interim final rule issued pursuant to 21 United States Code section 811(j) and published in the Federal Register.

B. Section 36-2511, Arizona Revised Statutes, as amended by Laws 2023, chapter 97, section 1 and this act does not become effective unless both the condition prescribed by Laws 2023, chapter 97, section 4 is met and on or before January 1, 2031 crystalline polymorph psilocybin is newly approved as a prescription medication pursuant to 21 United States Code section 355 and is controlled under a federal interim final rule issued pursuant to 21 United States Code section 811(j) and published in the Federal Register.

C. The executive director of the Arizona state board of pharmacy shall notify in writing the director of the Arizona legislative council on or before February 1, 2031 either:

1. Of the date on which the condition was met.

2. That the condition was not met.

 

 

 

APPROVED BY THE GOVERNOR JUNE 27, 2025.

 

FILED IN THE OFFICE OF THE SECRETARY OF STATE JUNE 27, 2025.